380 related articles for article (PubMed ID: 10631149)
41. Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair.
Healy E; Flannagan N; Ray A; Todd C; Jackson IJ; Matthews JN; Birch-Machin MA; Rees JL
Lancet; 2000 Mar; 355(9209):1072-3. PubMed ID: 10744096
[TBL] [Abstract][Full Text] [Related]
42. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.
Nan H; Kraft P; Hunter DJ; Han J
Int J Cancer; 2009 Aug; 125(4):909-17. PubMed ID: 19384953
[TBL] [Abstract][Full Text] [Related]
43. Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population.
Guedj M; Bourillon A; Combadières C; Rodero M; Dieudé P; Descamps V; Dupin N; Wolkenstein P; Aegerter P; Lebbe C; Basset-Seguin N; Prum B; Saiag P; Grandchamp B; Soufir N;
Hum Mutat; 2008 Sep; 29(9):1154-60. PubMed ID: 18683857
[TBL] [Abstract][Full Text] [Related]
44. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation.
Scott MC; Wakamatsu K; Ito S; Kadekaro AL; Kobayashi N; Groden J; Kavanagh R; Takakuwa T; Virador V; Hearing VJ; Abdel-Malek ZA
J Cell Sci; 2002 Jun; 115(Pt 11):2349-55. PubMed ID: 12006619
[TBL] [Abstract][Full Text] [Related]
45. Significance of the melanocortin 1 receptor in regulating human melanocyte pigmentation, proliferation, and survival.
Kadekaro AL; Kanto H; Kavanagh R; Abdel-Malek Z
Ann N Y Acad Sci; 2003 Jun; 994():359-65. PubMed ID: 12851336
[TBL] [Abstract][Full Text] [Related]
46. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
Goldstein AM; Chaudru V; Ghiorzo P; Badenas C; Malvehy J; Pastorino L; Laud K; Hulley B; Avril MF; Puig-Butille JA; Miniere A; Marti R; Chompret A; Cuellar F; Kolm I; Mila M; Tucker MA; Demenais F; Bianchi-Scarra G; Puig S; de-Paillerets BB
Int J Cancer; 2007 Aug; 121(4):825-31. PubMed ID: 17397031
[TBL] [Abstract][Full Text] [Related]
47. Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk.
Nan H; Qureshi AA; Hunter DJ; Han J
Br J Dermatol; 2008 Aug; 159(2):314-21. PubMed ID: 18510673
[TBL] [Abstract][Full Text] [Related]
48. Selected gene polymorphisms effect on skin and hair pigmentation in Polish children at the prepubertal age.
Sitek A; Rosset I; Żądzińska E; Siewierska-Górska A; Pietrowska E; Strapagiel D
Anthropol Anz; 2016 Nov; 73(4):283-293. PubMed ID: 27534414
[No Abstract] [Full Text] [Related]
49. Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis.
Dwyer T; van der Mei I; Ponsonby AL; Taylor BV; Stankovich J; McKay JD; Thomson RJ; Polanowski AM; Dickinson JL
Neurology; 2008 Aug; 71(8):583-9. PubMed ID: 18711112
[TBL] [Abstract][Full Text] [Related]
50. Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk.
Beaumont KA; Newton RA; Smit DJ; Leonard JH; Stow JL; Sturm RA
Hum Mol Genet; 2005 Aug; 14(15):2145-54. PubMed ID: 15972726
[TBL] [Abstract][Full Text] [Related]
51. Contributions by MC1R Variants to Melanoma Risk in Males and Females.
Wendt J; Mueller C; Rauscher S; Fae I; Fischer G; Okamoto I
JAMA Dermatol; 2018 Jul; 154(7):789-795. PubMed ID: 29898205
[TBL] [Abstract][Full Text] [Related]
52. MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project.
Pasquali E; García-Borrón JC; Fargnoli MC; Gandini S; Maisonneuve P; Bagnardi V; Specchia C; Liu F; Kayser M; Nijsten T; Nagore E; Kumar R; Hansson J; Kanetsky PA; Ghiorzo P; Debniak T; Branicki W; Gruis NA; Han J; Dwyer T; Blizzard L; Landi MT; Palmieri G; Ribas G; Stratigos A; Council ML; Autier P; Little J; Newton-Bishop J; Sera F; Raimondi S;
Int J Cancer; 2015 Feb; 136(3):618-31. PubMed ID: 24917043
[TBL] [Abstract][Full Text] [Related]
53. Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
Quint KD; van der Rhee JI; Gruis NA; Ter Huurne JA; Wolterbeek R; van der Stoep N; Bergman W; Kukutsch NA
Acta Derm Venereol; 2012 Nov; 92(6):587-92. PubMed ID: 22965007
[TBL] [Abstract][Full Text] [Related]
54. Screening of human primary melanocytes of defined melanocortin-1 receptor genotype: pigmentation marker, ultrastructural and UV-survival studies.
Leonard JH; Marks LH; Chen W; Cook AL; Boyle GM; Smit DJ; Brown DL; Stow JL; Parsons PG; Sturm RA
Pigment Cell Res; 2003 Jun; 16(3):198-207. PubMed ID: 12753386
[TBL] [Abstract][Full Text] [Related]
55. Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function.
Sánchez Más J; Olivares Sánchez C; Ghanem G; Haycock J; Lozano Teruel JA; García-Borrón JC; Jiménez-Cervantes C
Eur J Biochem; 2002 Dec; 269(24):6133-41. PubMed ID: 12473109
[TBL] [Abstract][Full Text] [Related]
56. Melanocortin receptors, red hair, and skin cancer.
Rees JL; Healy E
J Investig Dermatol Symp Proc; 1997 Aug; 2(1):94-8. PubMed ID: 9487023
[TBL] [Abstract][Full Text] [Related]
57. Variants of the melanocortin-1 receptor: do they matter clinically?
Haddadeen C; Lai C; Cho SY; Healy E
Exp Dermatol; 2015 Jan; 24(1):5-9. PubMed ID: 25219681
[TBL] [Abstract][Full Text] [Related]
58. Single nucleotide polymorphisms in the MATP gene are associated with normal human pigmentation variation.
Graf J; Hodgson R; van Daal A
Hum Mutat; 2005 Mar; 25(3):278-84. PubMed ID: 15714523
[TBL] [Abstract][Full Text] [Related]
59. Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects.
Kosiniak-Kamysz A; Marczakiewicz-Lustig A; Marcińska M; Skowron M; Wojas-Pelc A; Pośpiech E; Branicki W
Melanoma Res; 2014 Aug; 24(4):388-96. PubMed ID: 24926819
[TBL] [Abstract][Full Text] [Related]
60. Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.
Scherer D; Nagore E; Bermejo JL; Figl A; Botella-Estrada R; Thirumaran RK; Angelini S; Hemminki K; Schadendorf D; Kumar R
Int J Cancer; 2009 Oct; 125(8):1868-75. PubMed ID: 19585506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
